Foot And Mouth Disease Vaccine Market Report 2026

Foot And Mouth Disease Vaccine Market Overview

• Foot And Mouth Disease Vaccine market size has reached to $2.83 billion in 2025 • Expected to grow to $4.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Surge In Livestock Population Drives Growth In The Foot And Mouth Disease Vaccine Market • Market Trend: India’s Department Of Animal Husbandry Launches Third Phase Of FMD Vaccination Under NADCP For Comprehensive Livestock Health • Asia-Pacific was the largest region in 2025.

What Is Covered Under Foot And Mouth Disease Vaccine Market?

Foot-and-mouth disease (FMD) vaccines are a medication used to boost the immune system's defenses in animals against foot-and-mouth disease. FMD is a severe and highly infectious disease affecting all cloven-hoofed animals, including cattle, sheep, goats, camelids, deer, and pigs. Animals with the foot-and-mouth disease have a high body temperature, followed by blisters, primarily on the feet and in the mouth. The main types of foot and mouth disease vaccine are conventional vaccines, oil-based vaccines, aluminum hydroxide/saponin based vaccines, and emergency vaccines used for cattle, pig, sheep and goat, and other animals. Conventional vaccines comprise of inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. Conventional vaccines function by stimulating the immune system so that it will be ready to react more quickly and efficiently, if exposed to the infectious agent. The foot and mouth disease vaccine are distributed through various channels such as government organizations, distributors/ pharmacies, private vet, and other distribution channels.

What Is The Foot And Mouth Disease Vaccine Market Growth Forecast?

The foot and mouth disease vaccine market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to development of rapid response and diva vaccines, expansion of multi-species vaccination coverage, adoption of oil-adjuvanted and aluminum hydroxide-based vaccines, increasing government funding for FMD control, rising investments in cold chain and distribution infrastructure. Major trends in the forecast period include increasing adoption of emergency vaccines for rapid outbreak response, rising focus on multi-species fmd vaccination programs, development of diva (differentiating infected from vaccinated animals) vaccines, expansion of government-led immunization campaigns, growing use of oil-adjuvanted and aluminum hydroxide-based vaccines.

Global Foot And Mouth Disease Vaccine Market Segmentation

1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines 2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals 3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels Subsegments: 1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines 2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines 3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines 4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines

What Are The Drivers Of The Foot And Mouth Disease Vaccine Market?

The growing livestock population is driving the foot and mouth disease vaccine market. Livestock are farm animals housed, reared, and utilized by humans, including cows, horses, and pigs. There is a rise in the livestock population because of an increase in demand for animal products. As livestock increases, there is a chance of the prevalence of foot and mouth disease that can lead to market growth. For instance, in July 2023, according to the FAO, a US-based United Nations agency, world milk production in 2023 was forecast to increase to 944 million tonnes, up 0.9% from 2022, reflecting rising demand for animal-source foods as incomes increase and diets shift toward protein. Therefore, the growing livestock population will propel the foot and mouth disease vaccine industry. The increase in healthcare expenditure is expected to propel the growth of the foot and mouth disease vaccine market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific time frame. Healthcare expenditure supports research and development efforts in the field of veterinary medicine. Funding for research contributes to the development of more effective and advanced vaccines, including those for preventing foot and mouth disease in animals. For instance, in November 2025, according to the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, healthcare systems in member countries allocated on average 9.3% of GDP to health in 2024, and showing renewed growth in real per capita spending after 2023 stagnation, with average spending per person returning to above 3% annual growth. Therefore, the increase in healthcare expenditure is driving the growth of the foot and mouth disease vaccine industry.

Key Players In The Global Foot And Mouth Disease Vaccine Market

Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Merck & Co. Inc., Intervet India Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, FGBI‑ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, Alivira Animal Health Limited, Zoetis Inc., Dong Bang Co. Ltd., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Biovet Private Limited, MEVAC, SPIC Gene Science Technology Development Co. Ltd., VETAL Animal Health Products Inc., Southern Cross Group, VECOL S.A, Limor de Colombia

Global Foot And Mouth Disease Vaccine Market Trends and Insights

Major companies operating in the foot and mouth disease vaccine market are developing innovative services, such as clinical phases, to increase their profitability in the market. Clinical trials are research studies that test new treatments and medications. For instance, in June 2023, The Department of Animal husbandry and Dairying, an India-based ministry launched 3rd Phase of FMD Vaccination under NADCP. The third phase of the NADCP's FMD vaccination program is a thorough attempt to combat FMD in cattle and is a component of a larger plan to use vaccination to manage FMD by 2025 and eventually eradicate it by 2030. Improving local output and expanding milk and animal product exports are dependent on this project.

Regional Outlook

Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Foot And Mouth Disease Vaccine Market?

The foot and mouth disease vaccine market consist of sales of inactivated vaccine, viral vector vaccine, adenovirus, virus-like particle vaccines, baculovirus, plant-produced empty capsids, RNA vaccine, and DNA vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.